996.00 -22.05 (-2.17%)

37.34% Gain from 52W Low

77,903 NSE+BSE Volume

NSE 02 Jun, 2025 3:31 PM (IST)

US FDA Approval
Alembic Pharma receives US FDA approval for Bosutinib Tablets, with a market size of $291 million See details

Alembic Pharmaceuticals Ltd. RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Alembic Pharma technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis